Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun 1;37(4):233-233.
doi: 10.4274/balkanmedj.galenos.2020.2020.4.100. Epub 2020 Apr 24.

Ticagrelor Can Be an Important Agent in the Treatment of Severe COVID-19 Patients with Myocardial Infarction

Affiliations

Ticagrelor Can Be an Important Agent in the Treatment of Severe COVID-19 Patients with Myocardial Infarction

Ercan Akşit et al. Balkan Med J. .

Erratum in

  • Erratum.
    [No authors listed] [No authors listed] Balkan Med J. 2020 Aug 11;37(5):303. doi: 10.4274/balkanmedj.galenos.e001. Balkan Med J. 2020. PMID: 32777904 Free PMC article. No abstract available.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: No conflict of interest was declared by the authors.

References

    1. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18:844–7. - PMC - PubMed
    1. Acar L, Atalan N, Karagedik EH, Ergen A. Tumour Necrosis Factor-alpha and Nuclear Factor-kappa B Gene Variants in Sepsis. Balkan Med J. 2018;35:30–5. - PMC - PubMed
    1. Kubisa MJ, Jezewski MP, Gasecka A, Siller-Matula JM, Postula M. Ticagrelor-toward more efficient platelet inhibition and beyond. Ther Clin Risk Manag. 2018;14:129–40. - PMC - PubMed
    1. Sexton TR, Zhang G, Macaulay TE, Callahan LA, Charnigo R, Vsevolozhskaya OA, et al. Ticagrelor reduces thromboinflammatory markers in patients with pneumonia. JACC Basic Transl Sci. 2018;3:435–49. - PMC - PubMed
    1. Lancellotti P, Musumeci L, Jacques N, Servais L, Goffin E, Pirotte B, et al. Antibacterial activity of ticagrelor in conventional antiplatelet dosages against antibiotic-resistant Gram positive bacteria. JAMA Cardiol. 2019;4:596–9. - PMC - PubMed

MeSH terms